Notably, IL-1β, but not IL-18, participates in the development of metabolic syndromes by inhibiting adipocyte differentiation that is required for the maintenance of insulin sensitivity [240,241] and inducing inflammation [242]. This evidence concerns the gene IL18 and metabolic syndrome.